Annette Szumski

Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rheumatoid arthritis (PRESERVE): a randomised controlled trial

Josef S Smolen, Peter Nash, Patrick Durez et al. · The Lancet · 2013 · 354 citations · Full text

Medicine, Immunology, Pharmacotherapy +9

Female patients with ankylosing spondylitis: analysis of the impact of gender across treatment studies

Irene E. van der Horst‐Bruinsma, Debra Zack, Annette Szumski et al. · Annals of the Rheumatic Diseases · 2012 · 149 citations

Medicine, Clinical Sciences, Pharmacotherapy +13

How much does Disease Activity Score in 28 joints ESR and CRP calculations underestimate disease activity compared with the Simplified Disease Activity Index?

Roy Fleischmann, Désirée van der Heijde, Andrew Koenig et al. · Annals of the Rheumatic Diseases · 2014 · 140 citations

Medicine, Clinical Sciences, Internal Medicine +17

DAS28-CRP and DAS28-ESR cut-offs for high disease activity in rheumatoid arthritis are not interchangeable

Roy Fleischmann, Désirée van der Heijde, Philip Gardiner et al. · RMD Open · 2017 · 106 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +15

Discordance between patient and physician assessments of global disease activity in rheumatoid arthritis and association with work productivity

Josef S Smolen, Vibeke Strand, Andrew Koenig et al. · Arthritis Research & Therapy · 2016 · 68 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +15